These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Therapy with immunoglobulins with special regard to the problem of the efficacy of intravenously applied gammaglobulin in bacterial infections]. Duswald KH; Ring J Klin Anasthesiol Intensivther; 1980; 21():207-23. PubMed ID: 6161270 [No Abstract] [Full Text] [Related]
8. [Therapy with immunoglobulins]. Schumacher K Dtsch Med Wochenschr; 1986 Apr; 111(14):550-6. PubMed ID: 3514195 [No Abstract] [Full Text] [Related]
9. [The value of immunotherapy with parenteral gamma globulin]. Beaufort F; Auner H; Barandun S Wien Med Wochenschr; 1983; 133 Suppl 1():34-7. PubMed ID: 6197820 [No Abstract] [Full Text] [Related]
10. Evaluation of human viral disease transmission through plasma products. Heldebrant CM; Friedman AE; Fedor EJ Dev Biol Stand; 1987; 67():319-22. PubMed ID: 2440744 [TBL] [Abstract][Full Text] [Related]
11. Prophylactic and therapeutic use of immunoglobulin for intravenous administration in patients with secondary immunodeficiencies associated with malignancies. Morell A; Barandun S Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S87-91. PubMed ID: 2840630 [TBL] [Abstract][Full Text] [Related]
12. [Recurrent infections should be investigated with consideration to primary immunodeficiency]. Smith E; Hammarström L; Evengård B; Gardulf A; Björkander J Lakartidningen; 1992 Aug; 89(32-33):2593-7. PubMed ID: 1380625 [No Abstract] [Full Text] [Related]
13. Use of intravenous pH 4.0 treated gamma globulin in humoral immunodeficiency disease. Cunningham-Rundles C; Smithwick EM; Siegal FP; Day NK; Lion A; O'Malley J; Barandun S; Good RA Birth Defects Orig Artic Ser; 1983; 19(3):201-3. PubMed ID: 6197105 [No Abstract] [Full Text] [Related]
14. Intravenous gammaglobulin for immunodeficiency: report from The European Group for Immunodeficiencies (EGID). Clin Exp Immunol; 1986 Sep; 65(3):683-90. PubMed ID: 2430746 [TBL] [Abstract][Full Text] [Related]
15. Clinical tolerance and catabolism of plasmin-treated gamma-globulin for intravenous application. Barandun S; Castel V; Makula MF; Morell A; Plan R; Skvaril F Vox Sang; 1975; 28(3):157-75. PubMed ID: 47211 [TBL] [Abstract][Full Text] [Related]
16. Use of intravenous immunoglobulin to prevent or treat infections in persons with immune deficiency. Lee ML; Gale RP; Yap PL Annu Rev Med; 1997; 48():93-102. PubMed ID: 9046948 [TBL] [Abstract][Full Text] [Related]
17. The current status of intravenous gamma-globulin use in neonates. Gonzalez LA; Hill HR Pediatr Infect Dis J; 1989 May; 8(5):315-22. PubMed ID: 2471136 [No Abstract] [Full Text] [Related]
18. Editorial: Transfer-factor therapy of immunodeficiencies. Polmar SH N Engl J Med; 1973 Dec; 289(26):1420-1. PubMed ID: 4127762 [No Abstract] [Full Text] [Related]
19. Uses and abuses of plasma therapy in the patient with recurrent infections. Miller ME J Allergy Clin Immunol; 1973 Jan; 51(7):45-56. PubMed ID: 4118411 [No Abstract] [Full Text] [Related]
20. Adverse reactions of prophylactic intravenous immunoglobulin; a 13-year experience with 3004 infusions in Iranian patients with primary immunodeficiency diseases. Dashti-Khavidaki S; Aghamohammadi A; Farshadi F; Movahedi M; Parvaneh N; Pouladi N; Moazzami K; Cheraghi T; Mahdaviani SA; Saghafi S; Heydari G; Abdollahzade S; Rezaei N J Investig Allergol Clin Immunol; 2009; 19(2):139-45. PubMed ID: 19476018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]